Cooperation-Themed Visit By FDA Head Fails To Win Ranbaxy Reprieve
This article was originally published in PharmAsia News
Executive Summary
The glad-handing India visit of U.S. FDA Commissioner Margaret Hamburg and sequential announcements of cooperation on drug-regulation matters has not been enough to ease a ban on imports from Ranbaxy Laboratories.